Protective Role for Proteoglycans Against Cationic Lipid Cytotoxicity Allowing Optimal Transfection Efficiency in Vitro
Overview
Authors
Affiliations
A dependence on proteoglycans for cationic lipid-mediated gene transfer has been suggested in previous studies [Mislick and Baldeschwieler (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 12349-12354; Mounkes, Zhong, Cipres-Palacin, Heath and Debs (1998) J. Biol. Chem. 273, 26164-26170]. We have evaluated the mechanism of proteoglycan involvement in cationic lipid-mediated gene transfer. DNA plasmid uptake and gene expression were studied in wild-type Chinese hamster ovary (CHO) cells (CHO-K1), heparan sulphate-deficient CHO cells (pgsD-677) and proteoglycan-deficient CHO cells (pgsB-618). At an optimal ratio of cationic lipid to DNA, a substantial decrease in reporter gene expression was observed in proteoglycan-deficient cells compared with that in heparan sulphate-deficient and wild-type cells. However, there were no differences in reporter gene expression between the cell lines when transfected by electroporation. Moreover, all cell lines exhibited equal cationic-lipid-DNA complex uptake activities, as assessed by the measurement of intracellular (32)P-labelled and rhodamine-labelled DNA plasmid. An analysis of reflected-light images of wild-type and proteoglycan-deficient cells suggested that cationic lipids were preferentially toxic to proteoglycan-deficient cells. Cell-growth assays confirmed this, showing that cationic lipids exhibited a greater anti-proliferative activity in proteoglycan-deficient cells and in chlorate-treated wild-type cells than in the other cell lines. The growth-inhibitory effect of cationic lipids was abrogated by the addition of exogenous sulphated glycosaminoglycans. We conclude that the glycosaminoglycan part of proteoglycans serves a protective role against cationic lipid cytotoxicity, allowing optimal transfection efficiency in vitro.
Egorova A, Shtykalova S, Maretina M, Selutin A, Shved N, Deviatkin D Int J Mol Sci. 2022; 23(3).
PMID: 35163086 PMC: 8835468. DOI: 10.3390/ijms23031164.
Naik R, Chandra P, Mann A, Ganguli M J Biol Chem. 2011; 286(21):18982-93.
PMID: 21471199 PMC: 3099713. DOI: 10.1074/jbc.M111.227793.
Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands.
Payne C, Jones S, Chen C, Zhuang X Traffic. 2007; 8(4):389-401.
PMID: 17394486 PMC: 2715839. DOI: 10.1111/j.1600-0854.2007.00540.x.
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.
Torchilin V, Levchenko T, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B, DSouza G Proc Natl Acad Sci U S A. 2003; 100(4):1972-7.
PMID: 12571356 PMC: 149943. DOI: 10.1073/pnas.0435906100.
Harigai T, Kondo M, ISOZAKI M, Kasukawa H, Hagiwara H, Uchiyama H Pharm Res. 2001; 18(9):1284-90.
PMID: 11683241 DOI: 10.1023/a:1013033826974.